Email Updates

You are here

Home

16 NOVEMBER 2018 VOLUME 19 ISSUE 46

Media Coverage

  • Susan Buchbinder: Driving HIV prevention efforts worldwide

    Susan Buchbinder’s drive to fight the HIV epidemic started, as with many of her colleagues, when she was treating patients during the 1980s.

    November 17, 2018
    General
    Lancet

  • New HIV testing centers open in the Philippines as HIV crisis worsens

    More HIV testing centers have opened in the Philippines as the country struggles to curb the growing number of new cases. Already this year there have been more than 7,600 new HIV diagnosis in the Philippines. The south-east Asian nation has experienced a 174 percent increase in new infections since 2010.

    November 16, 2018
    General
    Gay Star News

  • South still center of new HIV infections, CDC says

    The HIV epidemic remains centered in the South, health officials say. And the region must overcome several factors before this disease burden will ease, they add.

    November 16, 2018
    General
    WABE

  • Pushing PrEP: Planned Parenthood targets gay men and heterosexual women

    Several patients are currently enrolled in the PrEP program in Norristown, with 10 more in Philadelphia since that program launched in July. While both initiatives were considered beta tests in Philly, the move is already being made to expand this service to more Planned Parenthood centers throughout the region. The challenge is educating people who may never have heard of PrEP about its benefits.

    November 16, 2018
    PrEP
    Philly Voice

  • Tops and bottoms prefer different forms of taking PrEP, study finds

    There are two other forms of taking PrEP that are currently in trial: long-acting injections to deliver antiretroviral (i.e., getting a shot once every 8–12 weeks) and topical microbicides (a cream you can either put in your anus or on your penis). There’s also a different regimen for taking PrEP called event-driven PrEP, where instead of Truvada daily, you take it surrounding the dates you know or believe that you’ll be having sex.

    November 15, 2018
    Microbicides, PrEP
    NewNowNext

  • HIV risk greatest during follicular phase of menstrual cycle

    The follicular phase of the menstrual cycle may be the most vulnerable time for HIV-1 acquisition in women—not the luteal phase, as previously thought—according to the results of a new study published online October 31 in The Journal of Infectious Diseases.

    November 15, 2018
    General
    Contagion Live

  • KEMRI probes Depo-Provera's link to high HIV risk

    Millions of Kenyan women using injectable contraception to prevent pregnancy will soon know if the method actually increases their risk of contracting HIV.

    November 15, 2018
    Hormonal Contraceptives and HIV
    The Star

  • Removable PrEP implant produces high drug levels in rabbits; further studies planned

    A small removable plastic implant resembling a tiny piece of dry spaghetti is capable of delivering sustained levels of the drug tenofovir, researchers told last month’s HIV Research for Prevention conference (HIVR4P 2018) in Madrid.

    November 15, 2018
    PrEP
    aidsmap

  • Uganda: Campaign to raise Shs10b for HIV fight launched

    More than 20 health workers and manufacturers have launched a campaign to raise Shs10b for HIV/AIDS treatment and national wide sensitization programmes.

    November 14, 2018
    General
    All Africa

  • Viral load in semen rapidly rebounds to infectious levels during HIV treatment breaks

    Increases in viral load in both blood and semen were observed within two weeks of treatment interruption. Four weeks after stopping therapy, all participants had detectable virus in their semen. Viral load in semen peaked at approximately 16,000 copies/ml, high enough for transmission to sexual partners.

    November 14, 2018
    Treatment
    aidsmap

  • 'Namibia is not there yet with AIDS'

    While Namibia's statistics for mother-to-child transmission of HIV stands at 4 percent, UNAIDS regional director Catherine Sozi says Namibia had not reached its destination in the fight against HIV-AIDS.

    November 14, 2018
    General
    Namibian

  • HIV prevention pill 'set up to fail' in some African countries

    The rollout of oral HIV pre-exposure prophylaxis (PrEP), a pill that prevents infection when taken daily, is not being managed well in parts of Africa.

    November 14, 2018
    PrEP
    Africa Portal

  • PROUD qualitative findings: PrEP’s impact on sexual behaviour

    Qualitative data from the PROUD study revealed that pre-exposure prophylaxis (PrEP) is an important added prevention tool to strategies already in place for men in England having frequent condomless sex, according to a recent article in AIDS and Behavior.

    November 13, 2018
    PrEP
    aidsmap

  • Providing HIV services

    In many countries in sub-Saharan Africa, HIV services are still offered separately within health facilities. These HIV clinics have their own dedicated staff and infrastructure such as waiting areas, a separate patient flow system and they typically run on designated days of the week.

    November 13, 2018
    General
    Independent

  • HIV: PrEP prevents infection, but uptake is still too low

    A study done in 10 counties (Kisumu, Migori, Kisii, Nairobi, Machakos, Kiambu, Mombasa, Kilifi, Kwale and Taita Taveta) revealed that there was a huge gap between participants who were screened and found eligible for PrEP, and those who were actually put on the preventive therapy.

    November 13, 2018
    PrEP
    Daily Nation

  • How innovation can help end the AIDS epidemic

    The main barrier is the time it takes to get test results back from laboratories that are often situated great distances from clinics. One way round the problem is to enable viral load testing to take place at primary health care level – what's known as point-of-care viral load testing. This would be a game changer. Results would be known immediately and health workers could intervene swiftly by evaluating antiretroviral treatments in real time. This would, in turn, improve treatment outcomes.

    November 13, 2018
    US News & World Report

  • HIV Trust Fund reach March 2019 – NACA

    The National Agency for the Control of AIDS (NACA) says the Nigerian HIV/AIDS Trust Fund will be functional by March 2019.

    November 13, 2018
    General
    Vanguard

  • Circumcision clinic launched in Delft

    The VMMC clinic was launched at the Airport Mall in Belhar as a joint initiative by the SA Department of Health with international, non-profit health organisation Jphiego yesterday.

    November 13, 2018
    Voluntary Medical Male Circumcision
    IOL

  • Big push to slash HIV infections in Brighton and Hove

    Brighton and Hove became the first city in Britain to sign up to the Fast Track Cities programme last year. It aims to make more than 90 percent of people with HIV aware that they have the virus.

    November 13, 2018
    Argus

  • Integrating the exceptional in an evolving response to AIDS

    Two central themes of the International AIDS Conference this summer appear, at first glance, to run at cross purposes. At Amsterdam, we heard both that AIDS programming is off track in achieving ambitious targets, and, at the same time, the AIDS response should look beyond a single disease focus to embrace broader goals including expanded access to primary health care.

    November 13, 2018
    General
    Friends of the Global Fight

  • Love & other drugs: Men could make all the difference in keeping your baby HIV free

    But Sibusiso Sifunda, the chief research specialist at the Human Sciences Research Council’s HIV Unit, says there is still very little acknowledgement of the role fathers can play in supporting exclusive breastfeeding and, in the process, prevent HIV transmission.

    November 12, 2018
    Treatment
    Bhekisisa

  • Study on contraceptives and HIV risk to be released mid-2019

    Dr. Timothy Mastro, a member of the ECHO (Evidence for Contraceptive Options and HIV Outcomes) management committee said they had concluded the study and that findings will be out by mid 2019.

    November 12, 2018
    Hormonal Contraceptives and HIV
    New Vision

  • To provide patient-centered HIV care, train on implicit bias

    All healthcare providers need it because "there are other things to consider" than just race, said Chandler. For example, targeting HIV prevention messages only to gay men does a disservice to women, who are acquiring HIV at increasing rates.

    November 12, 2018
    General
    Medscape

  • Fighting HIV/AIDS

    Uganda will in 2019 launch two researches aimed at preventing the spread of HIV/AIDS. The first, dubbed ‘Deliver’, will be based on ring laced with the HIV drug dapivirine being placed in the vagina and an oral drug Truvada taken daily as preventive (pre-exposure prophylaxis – PrEP) measures against HIV infection. The second study code-named MTN -043 will enroll up to 200 breast-feeding mothers to see whether the same drug can keep the mother and child safe.

    November 12, 2018
    Microbicides, PrEP
    Independent

  • New cell phone-based tool to detect HIV

    Scientists have designed a portable and low-cost diagnostic tool, utilising a cell phone and nanotechnology, which can detect HIV and monitor its management in resource-limited regions.

    November 12, 2018
    General
    Hindustan Times

  • Karamoja, Uganda embraces condom use in fight against HIV/AIDS

    The decline of HIV/AIDS prevalence in the region from 5.3 percent in 2003 to 3.4 percent in 2011 is attributed to the effective use of condoms.

    November 12, 2018
    Male and Female Condoms
    New Vision

  • You’ve heard that PrEP can prevent HIV, but so can PEP

    What’s more, the regimen works. “PEP is effective and has been used for decades by medical professionals to prevent infections after needlesticks,” Frye said. “Now, it is one more tool we can use to prevent HIV.”

    November 12, 2018
    General
    POZ

  • The POZ 100: Celebrating people 50 and over

    The ninth annual POZ 100 honors people living with HIV who are 50 and over and making a difference in the fight against the virus. This age group represents the future of the epidemic—both in the sheer number of people living with HIV and in the inspiring ways they’re thriving.

    November 12, 2018
    General
    POZ

  • Vaginal gel for HIV prevention so far ineffective in the real-world

    The FACTS-001 trial, led by the Wits Reproductive Health and HIV Institute in South Africa, was a Phase III clinical trial of a vaginal gel comprised of the antiretroviral drug, tenofovir, used before and after sex. The main outcome of the study was to assess whether use of the gel could prevent HIV acquisition among young women in the region, who remain the group most affected by HIV globally.

    November 9, 2018
    Microbicides
    Avert

Published Research

Announcements